An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
Background and purpose: Pancreatic cancer is a highly aggressive solid tumor of the digestive system, with radical resection being unfeasible in approximately 80% of patients due to the absence of specific clinical manifestations in the early stages. The use of gemcitabine as a first-line chemothera...
Saved in:
Main Authors: | REN Jiaqiang, WU Shuai, SU Tong, LI Jie, HAN Liang, WU Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Office of China Oncology
2024-12-01
|
Series: | Zhongguo aizheng zazhi |
Subjects: | |
Online Access: | http://www.china-oncology.com/CN/10.19401/j.cnki.1007-3639.2024.12.003 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer-associated fibroblast-derived COL17A1 promotes gemcitabine resistance and tumorigenesis in pancreatic cancer cells by interacting with ACTN4
by: Rongyu Shi, et al.
Published: (2025-02-01) -
Oncolytic influenza virus enhances killing effect of gemcitabine against pancreatic cancer cells
by: MENG Zihe, et al.
Published: (2025-01-01) -
Epithelial–Mesenchymal Transition Suppression by ML210 Enhances Gemcitabine Anti-Tumor Effects on PDAC Cells
by: Keisuke Takemura, et al.
Published: (2025-01-01) -
Bufalin targets the SRC-3/c-Myc pathway in chemoresistant cells to regulate metastasis induced by chemoresistance in colorectal cancer
by: Jinbao Chen, et al.
Published: (2025-02-01) -
UGCG promotes chemoresistance and breast cancer progression via NF-κB and Wnt/β-catenin pathway activation
by: Li Long, et al.
Published: (2025-02-01)